Michael Hayden - Director, Xenon Pharmaceuticals Inc

As of June 3, 2021


Michael Hayden Net Worth

  • Net worth is estimated to be at least $22.62M
  • Owns at least 191,535 units of Xenon Pharmaceuticals Inc stock

Michael Hayden Trading

  • Largest purchase of shares was 15,000 units , worth over $41.25K on August 14, 2017
  • In total has made about 19 transactions over 7 years
  • Usually trades in June, with the busiest year in 2021, 2017, 2015 and 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Michael Hayden Mailing Address

  • Mailing address is C/o Aspreva Pharmaceuticals Corporation 1203-4464 Markham Street Victoria A1 V8Z 7X8 British Columbia, Canada

Xenon Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 10,283 units sold on June 1, 2021 by Cassandra Robinson Attorney-In-Fact worth over $193.84K
  • In the last 6 years, insiders at Xenon Pharmaceuticals Inc sold an estimated value of $2.49M and bought an estimated value of $4.78M
  • The most active traders are Michael Tarnow, Director,  Michael Hayden, Director,  and Simon Pimstone, CEO
  • Insider trading is most common in June, with the busiest year in 2017

Xenon Pharmaceuticals Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1